The European Medicines Agency (EMA) is inviting healthcare professionals and academic researchers to take part in an important survey aimed at strengthening the use of Patient Experience Data (PED) in medicines regulation across Europe.
PED includes information reported directly by patients about their health, symptoms, treatment preferences, quality of life, and the impact of healthcare on their daily lives. This survey seeks your insights on how PED is currently used across different therapeutic areas and aims to identify gaps and unmet needs.
The survey takes only 10-15 minutes to complete, and your input will play a vital role in shaping the development and use of PED within the European Economic Area (EEA).
Access the survey here: PED Survey
We greatly appreciate your cooperation. Thank you in advance for your valuable contribution by close of business on 19 October 2025.
